You are accessing a machine-readable page. In order to be human-readable, please install an RSS reader.
All articles published by MDPI are made immediately available worldwide under an open access license. No special permission is required to reuse all or part of the article published by MDPI, including figures and tables. For articles published under an open access Creative Common CC BY license, any part of the article may be reused without permission provided that the original article is clearly cited. For more information, please refer to https://www.mdpi.com/openaccess.
Feature papers represent the most advanced research with significant potential for high impact in the field. A Feature Paper should be a substantial original Article that involves several techniques or approaches, provides an outlook for future research directions and describes possible research applications.
Feature papers are submitted upon individual invitation or recommendation by the scientific editors and must receive positive feedback from the reviewers.
Editor’s Choice articles are based on recommendations by the scientific editors of MDPI journals from around the world. Editors select a small number of articles recently published in the journal that they believe will be particularly interesting to readers, or important in the respective research area. The aim is to provide a snapshot of some of the most exciting work published in the various research areas of the journal.
Original Submission Date Received: .
It is with great sadness that we inform you of the passing of Biology Editorial Board Member Prof. Dr. Chris G. Dealwis in July 2022. Prof. Dr. Dealwis was an associate professor at the Department of Pharmacology and a member of the Case Comprehensive Cancer Center at Case Western Reserve University in Cleveland, OH, USA.
After earning his Ph.D. under Prof. Tom Blundell at Birkbeck College and subsequent training in industry and at Yale University, Prof. Dr. Dealwis started his career in the late 1990s. Over the following two decades, he led a remarkable research career in the fields of protein structure, function, and protein-based drug design. His research findings were used for the development of treatments for diseases such as cancer, Alzheimer’s disease, and microbial infections.
Over the years, Prof. Dr. Dealwis published more than 50 scientific papers in internationally peer-reviewed journals. He also led a Special Issue during his term serving as an Editorial Board Member in Biology: “Protein Drug Targets and Drug Design”.
His death is a significant loss to the academic community as well as anyone close to him. We offer our deepest condolences to his family, friends, and colleagues.
Biology Editorial Office